Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans

Journal of Clinical Microbiology

Volumn 44, Issue 3, 2006, Pages 892-898

  Liang, Kimberly P ^a,b   Tleyjeh, Imad M ^a   Wilson, Walter R ^a   Roberts, Glenn D ^a   Temesgen, Zelalem ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX;

ADULT; APOPHYSOMYCES ELEGANS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DIABETES MELLITUS; EXOPHTHALMOS; EYE SURGERY; FACE PAIN; HEAD INJURY; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; MALE; MUCORMYCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RHINOORBITOCEREBRAL MUCORMYCOSIS; ZYGOMYCETES;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; BRAIN DISEASES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCORALES; MUCORMYCOSIS; NOSE DISEASES; ORBIT EVISCERATION; ORBITAL DISEASES;

APOPHYSOMYCES ELEGANS; MUCOR; ZYGOMYCETES;

EID: 33644909116     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.3.892-898.2006     Document Type: Article

References (37)

1. Blair, J. E., L. J. Fredrikson, B. A. Pockaj, and C. S. Lucaire. 2002. Locally invasive cutaneous Apophysomyces elegans infection acquired from snapdragon patch test. Mayo Clin. Proc. 77:717-720.
2. Brown, S. R., I. A. Shah, and M. Grinstead. 1998. Rhinocerebral mucormycosis caused by Apophysomyces elegans. Am. J. Rhinol. 12:289-292.
3. Burrell, S. R., D. J. Ostlie, M. Saubolle, M. Dimler, and S. D. Barbour. 1998. Apophysomyces elegans infection associated with cactus spine injury in an immunocompetent pediatric patient. Pediatr. Infect. Dis. J. 17:663-664.
4. Caceres, A. M., C. Sardinas, C. Marcano, R. Guevara, J. Barros, G. Bianchi, V. Rosario, R. Balza, M. Silva, M. C. Redondo, and M. Nunez. 1997. Apophysomyces elegans limb infection with a favorable outcome: case report and review. Clin. Infect. Dis. 25:331-332.
5. Carter, J. E., and O. Ulusarac. 2003. Widespread cutaneous involvement by invasive Apophysomyces elegans in a gravid patient following trauma. Cutis 72:221-224, 227-228.
6. Chakrabarti, A., A. Das, A. Sharma, N. Panda, S. Das, K. L. Gupta, and V. Sakhuja. 2001. Ten years' experience in zygomycosis at a tertiary care centre in India. J. Infect. 42:261-266.
7. Chakrabarti, A., A. Ghosh, G. S. Prasad, J. K. David, S. Gupta, A. Das, V. Sakhuja, N. K. Panda, S. K. Singh, S. Das, and T. Chakrabarti. 2003. Apophysomyces elegans: an emerging zygomycete in India. J. Clin. Microbiol. 41:783-788.
8. Chakrabarti, A., P. Kumar, A. A. Padhye, L. Chatha, S. K. Singh, A. Das, J. D. Wig, and R. N. Kataria. 1997. Primary cutaneous zygomycosis due to Saksenaea vasiformis and Apophysomyces elegans. Clin. Infect. Dis. 24:580-583.
9. Chakrabarti A., N. Panda, S. C. Varma, K. Singh, A. Das, S. C. Sharma, and A. A. Padhye. 1997. Craniofacial zygomycosis caused by Apophysomyces elegans. Mycoses 40:419-421.
10. Cooler, R. D., I. S. Lim, D. H. Ellis, and I. O. Leitch. 1990. Burn wound zygomycosis caused by Apophysomyces elegans. J. Clin. Microbiol. 28:2151-2153.
11. Dannaoui, E., J. F. Meis, D. Loebenberg, and P. E. Verweij. 2003. Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob. Agents Chemother. 47:3647-3650.
12. Dannaoui, E., J. W. Mouton, J. F. G. M. Meis, P. E. Verweij, and the Eurofung Network. 2002. Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis. Antimicrob. Agents Chemother. 46:1953-1959.
13. Eaton, M. E., A. A. Padhye, D. A. Schwartz, and J. P. Steinberg. 1994. Osteomyelitis of the sternum caused by Apophysomyces elegans. J. Clin. Microbiol. 32:2827-2828.
14. Ellis, D. H. 2005. Systemic zygomycosis, p. 659-686. In W. G. Merz and R. J. Hay (ed.), Topley & Wilson's microbiology and microbial infections, medical mycology, 10th ed. Hodder Arnold, London, United Kingdom.
15. Fairley, C., T. J. Sullivan, P. Bartley, T. Allworth, and R. Lewandowski. 2000. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Ophthalmology 107:555-558.
16. Fung-Tomc, J. C., E. Huczko, B. Minassian, and D. P. Bonner. 1998. In vitro activity of a new oral triazole, BMS-207147 (ER-30346). Antimicrob. Agents Chemother. 42:313-318.
17. Garcia-Covarrubias, L., R. Bartlett, D. M. Barratt, and R. J. Wassermann. 2001. Rhino-orbitocerebral mucormycosis attributable to Apophysomyces elegans in an immunocompetent individual: case report and review of the literature. J. Trauma 50:353-357.
18. Herbrecht, R. 2004. Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections. Int. J. Clin. Pract. 58:612-624.
19. Huffnagle, K. E., P. M. Southern, Jr., L. T. Byrd, and R. M. Gander. 1992. Apophysomyces elegans as an agent of zygomycosis in a patient following trauma. J. Med. Vet. Mycol. 30:83-86.
20. Kimura, M., M. B. Smith, and M. R. McGinnis. 1999. Zygomycosis due to Apophysomyces elegans: report of 2 cases and review of the literature. Arch. Pathol. Lab. Med. 123:386-390.
21. Lakshmi, V., T. S. Rani, S. Sharma, V. S. Mohan, C. Sundaram, R. R. Rao, and G. Satyanarayana. 1993. Zygomycotic necrotizing fasciitis caused by Apophysomyces elegans. J. Clin. Microbiol. 31:1368-1369.
22. Lawrence, R. M., W. T. Snodgrass, G. W. Reichel, A. A. Padhye, L. Ajello, and F. W. Chandler. 1986. Systemic zygomycosis caused by Apophysomyces elegans. J. Med. Vet. Mycol. 24:57-65.
23. Lesueur, B. W., K. Warschaw, and L. Fredrikson. 2002. Necrotizing cellulitis caused by Apophysomyces elegans at a patch test site. Am. J. Contact Dermatitis. 13:140-142.
24. Mathews, M. S., A. Raman, and A. Nair. 1997. Nosocomial zygomycotic post-surgical necrotizing fasciitis in a healthy adult caused by Apophysomyces elegans in south India. J. Med. Vet. Mycol. 35:61-63.
25. McGinnis, M. R., J. Midez, L. Pasarell, and A. Haque. 1993. Necrotizing fasciitis caused by Apophysomyces elegans. J. Mycol. Med. 3:175-179.
26. Meis, J. F., B. J. Kullberg, M. Pruszczynski, and R. P. Veth. 1994. Severe osteomyelitis due to the zygomycete Apophysomyces elegans. J. Clin. Micro-biol. 32:3078-3081.
27. Naguib, M. T., M. M. Huycke, J. A. Pederson, L. R. Pennington, M. E. Burton, and R. A. Greenfield. 1995. Apophysomyces elegans infection in a renal transplant recipient. Am. J. Kidney Dis. 26:381-384.
28. Okhuysen, P. C., J. H. Rex, M. Kapusta, and C. Fife. 1994. Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegans. Clin. Infect. Dis. 19:329-331.
29. Page, R., D. J. Gardam, and C. H. Heath. 2001. Severe cutaneous mucormycosis (zgomycosis) due to Apophysomyces elegans. ANZ J. Surg. 71:184-186.
30. Pitisuttithum, P., R. Negroni, J. R. Graybill, B. Bustamante, P. Pappas, S. Chapman, R. S. Hare, and C. J. Hardalo. 2005. Activity of posaconazole in the treatment of central nervous system fungal infections. J. Antimicrob. Chemother. 56:745-755.
31. Radner, A. B., M. D. Witt, and J. E. Edwards, Jr. 1995. Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: case report and review. Clin. Infect. Dis. 20:163-166.
32. Sugar, A. M. 2005. Agents of mucormycosis and related species, p. 2973-2984. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's Principles and practice of infectious diseases, 6th ed., vol. 2. Elsevier Churchill Livingstone, Philadelphia, Pa.
33. Sun, Q. N., L. K. Najvar, R. Bocanegra, D. Loebenberg, and J. R. Graybill. 2002. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob. Agents Chemother. 46:2310-2312.
34. Tobon, A. M., M. Arango, D. Fernandez, and A. Restrepo. 2003. Mucormycosis (Zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy. Clin. Infect. Dis. 36:1488-1491.
35. Walsh, T. J., J. W. Hiemenz, N. L. Seibel, J. R. Perfect, G. Horwith, L. Lee, J. L. Silber, M. J. DiNubile, A. Reboli, E. Bow, J. Lister, and E. J. Anaissie. 1998. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin. Infect. Dis. 26:1383-1396.
36. Weinberg, W. G., B. H. Wade, G. Cierny III, D. Stacy, and M. G. Rinaldi. 1993. Invasive infection due to Apophysomyces elegans in immunocompetent hosts. Clin. Infect. Dis. 17:881-884.
37. Wieden, M. A., K. K. Steinbronn, A. A. Padhye, L. Ajello, and F. W. Chandler. 1985. Zygomycosis caused by Apophysomyces elegans. J. Clin. Microbiol. 22:522-526.